Effectiveness of venlafaxine in patients with ankylosing spondylitis with a neuropathic component of the pain syndrome

Author:

Kedyk I. O.ORCID,Stanislavchuk M. A.ORCID

Abstract

Annotation. In aim to study the effectiveness of the use of venlafaxine in the complex therapy of ankylosing spondylitis in the presence of neuropathic pain, the results of treatment of 131 patients with ankylosing spondylitis were studied: 88 patients without neuropathic pain, 22 patients with neuropathic pain who received standard treatment, and 21 patients with neuropathic pain who received venlafaxine in addition to standard therapy. Statistical analysis of differences in quantitative features was performed using the non-parametric Mann-Whitney test, categorized using Fisher's exact test (one-sided) at p<0.05. Significantly better dynamics in the course of treatment were found in patients with neuropathic pain treated with venlafaxine compared to patients with neuropathic pain and without neuropathic pain treated with standard therapy. ASAS20 compliance was achieved in 31.8% of patients without neuropathic pain and in 13.6% of patients with neuropathic pain who received standard therapy and in 47.6% of patients with neuropathic pain who received venlafaxine in addition to standard therapy. The calculation of the odds ratio proved that the presence of neuropathic pain increases the risk of resistance to treatment (failure to achieve ASAS20 by almost three times (odds ratio 2.95; confidence interval 0.8-10.8). Prescribing venlafaxine to patients with ankylosing spondylitis and the presence of neuropathic pain increases the chances of achieving ASAS20 by 5.75 times with a confidence interval of 1.3-25.5 (p<0.05). Patients who received venlafaxine in addition to standard therapy achieved significantly better scores on BASMI, ASAS, HAQ, depression and reactive anxiety after 12-week therapy. This gives reasons to recommend the introduction of venlafaxine to the treatment regimen of AS in the presence of neuropathic pain

Publisher

Vinnytsia National Pyrogov Memorial Medical University

Subject

General Medicine

Reference34 articles.

1. Kedyk, I. O. (2022). Нейропатичний біль при анкілозивному спондиліті та особливості психопатологічного реагування [Neuropathic pain in ankylosing spondylitis and features of psychopathological response]. Український журнал медицини, біології та спорту – Ukrainian Journal of Medicine, Biology and Sports, 7, 6(40), 89-94. doi: 10.26693/jmbs07.06.089

2. Kedyk, I. O., Shalkovskyi, E. I., Shapoval, I. I., & Stanislavchuk, M. A. (2022). Крос-культуральна адаптація та валідізація україномовної версії Standardized Evaluation of Pain (StEP) – інструменту оцінки нейропатичного болю в нижній частині спини у хворих на анкілозивний спондиліт [Cross-cultural adaptation and validation of the Ukrainian version of the Standardized Evaluation of Pain (StEP) – a tool for assessing neuropathic pain in the lower back in patients with ankylosing spondylitis]. Український неврологічний журнал – Ukrainian neurological journal, 3-4, 39-48. doi: 10.30978/UNJ2022-3-39

3. Maruta, N. A., Panko, T. V., Yavdak, I. A., & Semykina, E. E. (2004). Критерий качества жизни в психиатрической практике [Criterion of quality of life in psychiatric practice]. Харьков – Kharkiv: RIF Arsis, LTD.

4. Stanislavchuk, M. A., Shapoval, I. I., & Zaichko, K. O. (2016). Адаптація та валідизація україномовної версії ASAS Health Index and Environmental Factors у хворих на анкілозивний спондилоартрит [Adaptation and validation of the Ukrainian version of the ASAS Health Index and Environmental Factors in patients with ankylosing spondylitis]. Український ревматологічний журнал – Ukrainian Journal of Rheumatology, 65(3), 55-58.

5. Shapoval, I. I., & Stanislavchuk, M. A. (2021). Вплив дулоксетину на ефективність лікування хворих на анкілозивний спондиліт за умов коморбідності з фіброміалгією [Effect of duloxetine on treatment efficacy in patients with ankylosing spondylitis comorbid with fibromyalgia]. Український ревматологічний журнал – Ukrainian Journal of Rheumatology, 1(83), 27-33. doi: 10.32471/rheumatology.2707-6970.83.15947

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3